AH
AHaron
Community Contributor
Member since 2026
Views
3.2k Total number of views
Fair Values Set
18 Total number of fair values set
Comments
0 Total number of comments
Followers
5 Total number of followers
Economics student and self-taught investor focused on high-growth equities and pipeline-stage pharmaceuticals. I look for businesses where the real story hasn't been priced in yet. Based in Brisbane, Australia.
No link added
Eli Lilly: A Pipeline-Driven Growth Story Trading 30% Below What the Business Is Actually Worth
Eli Lilly’s weight-loss and diabetes medicines keep driving rapid growth, and a new treatment in late-stage testing could make that lead even bigger. The catch is that tougher competition and tighter drug pricing could squeeze profits, so the next round of trial and approval news matters.Read more